Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.14 -0.01 (-0.36%)
As of: Oct 21, 2026 · 1:45 PM EDT

Oramed Pharmaceuticals (ORMP) EV to EBIT (2013 - 2016)

Updated

Oramed Pharmaceuticals' (ORMP) EV to EBIT came in at 32.55 for FY2021.

Analysis

Oramed Pharmaceuticals (ORMP) EV to EBIT (2013 - 2016) Analysis & Trends

  • Business Quant data shows ORMP's EV to EBIT at 4.67 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.24 Bn 1,102.83 Bn 19.71 Bn
2 Johnson & Johnson 616.05 Bn 534.58 Bn 17.26 Bn
3 AbbVie 500.90 Bn 474.01 Bn 12.70 Bn
4 Merck 367.17 Bn 321.54 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn
7 Amgen 235.77 Bn 191.17 Bn 7.24 Bn
8 Gilead Sciences 190.70 Bn 164.90 Bn 6.22 Bn
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn
10 Oramed Pharmaceuticals 169.70 Mn -165.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2016 227.50
May 31, 2014 11.06
Feb 28, 2014 35.66
Nov 30, 2013 16.45
Aug 31, 2013 12.69
API Access

Oramed Pharmaceuticals EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=ORMP&period=max&api_key=YOUR_API_KEY